Assertio Holdings, Inc. to Release Q2 2025 Financial Results and Host Webcast on August 11, 2025

Assertio Holdings will announce Q2 2025 financial results on August 11, followed by a webcast at 4:30 PM ET.

Quiver AI Summary

Assertio Holdings, Inc. announced that it will release its second quarter 2025 financial results on August 11, 2025, after market close, followed by a live webcast conference call at 4:30 p.m. Eastern Time to discuss the results and share updates on its 2025 strategic plans. Interested parties can access the webcast and conference call details through Assertio's investor relations website. For those who prefer to join by phone, a specific dial-in number is provided. A replay of the webcast will be available shortly after the call. Assertio focuses on offering differentiated pharmaceutical products in oncology, neurology, and pain management to meet patient needs.

Potential Positives

Assertio will provide financial results for Q2 2025, indicating transparency and accountability to investors.
The live webcast conference call offers investors direct access to management insights and updates on 2025 strategic plans.
Assertio's focus on key therapeutic areas like oncology, neurology, and pain management highlights its commitment to addressing significant patient needs.
The availability of a replay for the conference call ensures that stakeholders can access important information at their convenience.

Potential Negatives

Announcement of financial results may indicate issues with transparency if there are predictions of poor performance or missing estimates.
The timing of the financial release and subsequent call may suggest urgency or alarm if they follow a trend of disappointing quarterly results.
Failure to provide advanced disclosures or address potential challenges in the business could lead to decreased investor confidence.

FAQ

When will Assertio release its Q2 2025 financial results?

Assertio will release its Q2 2025 financial results on Monday, August 11, 2025, after the market close.

What time is the Assertio conference call?

The live webcast conference call is scheduled for 4:30 p.m. Eastern Time on August 11, 2025.

How can I access the live webcast for Assertio's financial results?

You can access the live webcast by visiting Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx.

What is the call ID for the telephone conference call?

The call ID for the telephone conference call is 3278948.

Will there be a replay of the conference call?

Yes, a webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$ASRT Hedge Fund Activity

We have seen 19 institutional investors add shares of $ASRT stock to their portfolio, and 44 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RUSSELL INVESTMENTS GROUP, LTD. removed 424,059 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $286,070
MILLENNIUM MANAGEMENT LLC removed 316,702 shares (-28.8%) from their portfolio in Q1 2025, for an estimated $213,647
NANTAHALA CAPITAL MANAGEMENT, LLC added 291,426 shares (+3.6%) to their portfolio in Q1 2025, for an estimated $196,595
RENAISSANCE TECHNOLOGIES LLC removed 289,050 shares (-9.7%) from their portfolio in Q1 2025, for an estimated $194,993
AQR CAPITAL MANAGEMENT LLC removed 265,795 shares (-29.4%) from their portfolio in Q1 2025, for an estimated $179,305
UBS GROUP AG removed 246,996 shares (-53.7%) from their portfolio in Q1 2025, for an estimated $166,623
TWO SIGMA INVESTMENTS, LP removed 240,586 shares (-26.4%) from their portfolio in Q1 2025, for an estimated $162,299

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ASRT Analyst Ratings

Wall Street analysts have issued reports on $ASRT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 05/19/2025

To track analyst ratings and price targets for $ASRT, check out Quiver Quantitative's $ASRT forecast page.

Full Release

LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx . Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com .

Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
[email protected]